Knowledge Resource Center for Ecological Environment in Arid Area
DOI | 10.1002/dmrr.208 |
The evolving rote of oral insulin in the treatment of diabetes using a novel RapidMist (TM) System | |
Modi, P; Mihic, M; Lewin, A | |
通讯作者 | Modi, P |
会议名称 | 6th International St Bartholmew Symposium on Diabetes - New Therapies and Technologies |
会议日期 | 2002 |
会议地点 | ST BARTHOLOMEW, ENGLAND |
英文摘要 | The inability of subcutaneous (sc) insulin to effectively, safely and painlessly control postprandial glucose levels has encouraged the exploration of alternate methods of insulin delivery. Recently, a novel drug delivery system, based on a unique liquid aerosol formulation, has been developed. This system allows precise insulin dose delivery via a simple, cosmetically acceptable metered dose inhaler in the form of fine aerosolized droplets directed into the mouth. The system introduces a fine-particle aerosol at high velocity into the patient's breath; the mouth deposition is dramatically increased compared with conventional technology. This oral aerosol formulation is rapidly absorbed through the buccal mucosal lining and in the oropharynx regions, and it provides the plasma insulin levels necessary to control postprandial glucose rise in diabetic patients. This novel, pain-free, oral insulin formulation has a critical series Of attributes: rapid absorption, a simple (user-friendly) administration technique, precise dosing control (comparable to injection within one unit), and bolus delivery of drug. This review describes the recent results of clinical studies (in type I arid type 2 diabetic patients) by comparing the efficacy of Oralin(TM) (oral insulin spray) versus sc injected insulin and placebo arms. A simplified means for prandial insulin delivery, such as that offered by this technique, will significantly reduce the incidence of key complications by allowing increased patient compliance for consistent drug administration in order to regulate patients' blood glucose levels. Copyright (C) 2002 John Wiley Sons, Ltd. |
英文关键词 | Oralin type 2 diabetes RapidMist (TM) mixed micelles aerosolized insulin |
来源出版物 | DIABETES-METABOLISM RESEARCH AND REVIEWS |
ISSN | 1520-7552 |
出版年 | 2002 |
卷号 | 18 |
页码 | S38-S42 |
出版者 | JOHN WILEY & SONS LTD |
类型 | Article;Proceedings Paper |
语种 | 英语 |
国家 | Canada;USA |
收录类别 | CPCI-S ; SCI-E |
WOS记录号 | WOS:000175030600006 |
WOS关键词 | THERAPY |
WOS类目 | Endocrinology & Metabolism |
WOS研究方向 | Endocrinology & Metabolism |
资源类型 | 会议论文 |
条目标识符 | http://119.78.100.177/qdio/handle/2XILL650/293752 |
作者单位 | (1)Generex Biotechnol Corp, Toronto, ON M5J 2G2, Canada;(2)Univ Toronto, St Joseph Hosp, Toronto, ON, Canada;(3)Natl Res Inst, Los Angeles, CA USA |
推荐引用方式 GB/T 7714 | Modi, P,Mihic, M,Lewin, A. The evolving rote of oral insulin in the treatment of diabetes using a novel RapidMist (TM) System[C]:JOHN WILEY & SONS LTD,2002:S38-S42. |
条目包含的文件 | 条目无相关文件。 |
个性服务 |
推荐该条目 |
保存到收藏夹 |
导出为Endnote文件 |
谷歌学术 |
谷歌学术中相似的文章 |
[Modi, P]的文章 |
[Mihic, M]的文章 |
[Lewin, A]的文章 |
百度学术 |
百度学术中相似的文章 |
[Modi, P]的文章 |
[Mihic, M]的文章 |
[Lewin, A]的文章 |
必应学术 |
必应学术中相似的文章 |
[Modi, P]的文章 |
[Mihic, M]的文章 |
[Lewin, A]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。